Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LIN28A | Q9H9Z2 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1760709 | 1.00 | HRH1 (0.52) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL27657995 | 0.89 | HRH1 (0.51) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL6765343 | 0.84 | HRH1 (0.55) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL4572590 | 0.83 | HRH1 (0.50) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL4572586 | 0.83 | HRH1 (0.50) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL5442492 | 0.81 | HRH1 (0.57) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL26936292 | 0.81 | HRH3 (0.41) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL4572593 | 0.80 | HRH3 (0.47) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL28985167 | 0.80 | HRH1 (0.50) | HRH1HRH3ALDH1A1LMNATAAR1 | |
| SCHEMBL10810253 | 0.80 | HRH1 (0.50) | HRH1HRH3ALDH1A1LMNATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| US-20200299130-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| US-20130303466-A1 | Chemosensory Receptor Ligand-Based Therapies | ELCELYX THERAPEUTICS, INC. (US) | 2013-11-14 | — | — | US | disclosed |
| US-20130303466-A1 | Chemosensory Receptor Ligand-Based Therapies | ELCELYX THERAPEUTICS, INC. (US) | 2013-11-14 | — | — | US | disclosed |
| WO-2012054527-A2 | CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES | ELCELYX THERAPEUTICS, INC. (US) | 2012-04-26 | — | — | WO | disclosed |
| US-20110114075-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. | 2011-05-19 | — | — | US | disclosed |
| EP-2318307-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | Blacklight Power, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010014684-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BLACKLIGHT POWER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| US-20070072096-A1 | Negative curable dye-containing composition, color filter, and method of manufacturing the same | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| EP-0891970-B1 | Process for producing alkenylsubstituted pyridine derivatives | SUMITOMO CHEMICAL CO (JP) | 2004-10-13 | — | — | EP | disclosed |
| US-6008364-A | Process for producing alkenyl--substituted pyridine derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1999-12-28 | — | — | US | disclosed |
| EP-0891970-A1 | Process for producing alkenylsubstituted pyridine derivatives | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1999-01-20 | — | — | EP | disclosed |
| US-5658706-A | CONTAINING COMPOUND WHICH DECOMPOSES INTO AN ACID | KABUSHIKI KAISHA TOSHIBA (JP) | 1997-08-19 | — | — | US | disclosed |
| EP-0503780-B1 | Polymerizable metal-azo and metal-azomethine dyes | MINNESOTA MINING & MFG (US) | 1997-01-08 | — | — | EP | disclosed |
| EP-0508573-B1 | Transfer imaging using metal-azo and metal-azomethine dyes | MINNESOTA MINING & MFG (US) | 1995-06-07 | — | — | EP | disclosed |
| US-5180705-A | Monoazo or methine metallized dyes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-01-19 | — | — | US | disclosed |
| US-5166326-A | POLYMERIZABLE METAL-AZO AND METAL-AZOMETHINE DYES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-11-24 | — | — | US | disclosed |
| EP-0508573-A1 | Transfer imaging using metal-azo and metal-azomethine dyes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303466-A1 | Chemosensory Receptor Ligand-Based Therapies | GPR119, TAS1R2, TAS2R1 | HRH1 836/4885HRH3 1057/4885ALDH1A1 796/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | HRH1 540/4885HRH3 273/4885ALDH1A1 3874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.